06 October 2020: Database Analysis
Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics
Honggang Ke 1CD* , Yunyu Wu 2DEF* , Runjie Wang 3CDF , Xiaohong Wu 4AB*DOI: 10.12659/MSM.925833
Med Sci Monit 2020; 26:e925833
Supplementary Table 1 Clinical and chi-square test information for samples in clusters 1 and 2.
| Clinical characteristics | Cluster 1 | Cluster 2 | X-squared | P value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pathologic N (N0/N1/N2) | 93 | 36 | 28 | – | 121 | 24 | 27 | – | 5.4091 | 0.0467 |
| Pathologic T (T1/T2/T3/T4) | 48 | 93 | 14 | 5 | 63 | 87 | 15 | 9 | 2.8225 | 0.4198 |
| Pathologic stage (I/II/III/IV) | 82 | 42 | 31 | 5 | 98 | 39 | 30 | 8 | 1.5735 | 0.6654 |
| New tumor (yes/no) | 47 | 84 | – | – | 57 | 92 | – | – | 0.0823 | 0.7742 |